Date:3/5/2010

49 2,239 1,930 13,176 5,107 Amortization 36 243 243 107 728 728 Earnings before interest, tax, depreciation and amortization 4,320 29,485 27,362 12,627 86,196 64,450 ("Non-GAAP EBITDA") Exhibit 4 CHINA CORD BLOOD CORPORATION Reconciliations of non-GAAP EPS to the nearest comparable GAAP measures 3 Months 3 Months 9 Months 9 Months Ended Ended Ended Ended Dec 09 Dec 08 Dec 09 Dec 08 NUMERATOR ('RMB'000) GAAP net income attributable to China Cord Blood Corporation shareholders 20,001 12,836 33,048 576 Pro forma adjustments Income attributable to redeemable noncontrolling interest -- -- 347 -- Write-off of deferred reverse recapitalization costs -- -- 21,566 -- Non-GAAP net income attributable to shareholders 20,001 12,836 54,961 576 DENOMINATOR ('000 shares) Weighted average ordinary shares issued and outstanding 64,377 43,237 56,252 43,237 Add: Issue of ordinary shares upon share exchange with ordinary shareholders of China Cord Blood Services Corporation In June 2009 -- 12,476 4,159 12,476 Add: Issue of ordinary shares for redeemable share exchange in Aug 2009 -- 3,506 1,719 3,506 Pro forma weighted average ordinary shares issued and outstanding 64,377 59,219 62,130 59,219 Non-GAAP basic earnings attributable to shareholders (RMB) 0.31 0.22 0.88 0.01 Non-GAAP basic earnings a
'/>"/>

SOURCE China Cord Blood Corporation Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Related biology technology :

1. Tianyin Pharmaceutical Co., Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing on March 9
2. China Sky One Medical to Attend Rodman & Renshaw Annual China Investment Conference
3. China Baicaotang to Attend Rodman & Renshaw Annual China Investment Conference
4. China Medical Technologies Reports Third Fiscal Quarter Financial Results
5. Nutrastar International, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing
6. China-Biotics, Inc. Appointed Grayling as Strategic Investor Relations Advisor
7. China-Biotics, Inc. Inaugurated the Commercial Production of its New Production Facility
8. China Sky One Medical Confirms Continued Sale of Seven of Eight Products on the Ministry of Healths Warning List
9. China-Biotics, Inc. Reports Third Quarter Fiscal 2010 Financial Results
10. China Medical Technologies to Participate Investor Conferences in March 2010
11. China Biologic Products Responds to Allegations on Financial Websites